Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Capricor Therapeutics, Inc. CAPR

Full chart Compare
Set alert

Price alert · CAPR

All alert types
8.00 USD -0.24 (-2.91%)

Nov 4, 2026, 10:25 AM EST

7.92 Day range 8.55
2.96 52-week range 40.37
YTD
-72.28%
1 year
+32.01%

Financial health

Altman Z-Score

0.45 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 1

Valuation

P/E -12.8×
FY 2016: -2.6×FY 2017: 15.8×FY 2018: -0.8×FY 2019: -0.6×FY 2020: -3.9×FY 2021: -3.4×FY 2022: -3.3×FY 2023: -5.9×FY 2024: -12.0×FY 2025: -12.8×
FY 2016 5y median -5.9× FY 2025
P/S 0.0×
FY 2016: 15.5×FY 2017: 13.7×FY 2018: 7.2×FY 2019: 4.7×FY 2020: 172×FY 2021: 276×FY 2022: 37.1×FY 2023: 5.2×FY 2024: 21.8×FY 2025: 0.0×
FY 2016 5y median 21.8× FY 2025
P/B 4.4×
FY 2016: -12.3×FY 2017: 3.3×FY 2018: 2.6×FY 2019: 0.7×FY 2020: 1.9×FY 2021: 2.2×FY 2022: 8.0×FY 2023: 5.8×FY 2024: 3.3×FY 2025: 4.4×
FY 2016 5y median 4.4× FY 2025
P/FCF -18.4×
FY 2016: -3.1×FY 2017: -2.6×FY 2018: -0.8×FY 2019: -0.7×FY 2020: -5.0×FY 2021: -3.8×FY 2022: 60.9×FY 2023: -4.7×FY 2024: -11.7×FY 2025: -18.4×
FY 2016 5y median -4.7× FY 2025
EV/EBITDA -10.7×
FY 2016: -3.4×FY 2017: 11.4×FY 2018: -0.7×FY 2019: -0.6×FY 2020: -1.8×FY 2021: -2.0×FY 2022: -3.2×FY 2023: -5.7×FY 2024: -12.3×FY 2025: -10.7×
FY 2016 5y median -5.7× FY 2025
EV/Sales 0.0×
FY 2016: 19.8×FY 2017: 12.7×FY 2018: 6.7×FY 2019: 4.2×FY 2020: 78.8×FY 2021: 159×FY 2022: 35.7×FY 2023: 4.8×FY 2024: 21.5×FY 2025: 0.0×
FY 2016 5y median 21.5× FY 2025
FCF Yield -5.4%
FY 2016: -32.4%FY 2017: -38.9%FY 2018: -117.7%FY 2019: -143.6%FY 2020: -19.9%FY 2021: -26.6%FY 2022: 1.6%FY 2023: -21.1%FY 2024: -8.5%FY 2025: -5.4%
FY 2016 5y median -8.5% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -402.9%FY 2017: 100.0%FY 2018: 100.0%FY 2019: -411.6%FY 2020: 100.0%FY 2021: 100.0%FY 2022: -755.1%FY 2023: -44.8%FY 2024: -124.4%FY 2025: 0.0%
FY 2016 5y median -44.8% FY 2025
Operating Margin 0.0%
FY 2016: -532.2%FY 2017: -482.4%FY 2018: -917.2%FY 2019: -769.5%FY 2020: -4412.6%FY 2021: -8549.9%FY 2022: -1163.9%FY 2023: -95.6%FY 2024: -191.1%FY 2025: 0.0%
FY 2016 5y median -191.1% FY 2025
Net Margin 0.0%
FY 2016: -589.6%FY 2017: 91.2%FY 2018: -909.1%FY 2019: -760.4%FY 2020: -4401.9%FY 2021: -8175.9%FY 2022: -1137.4%FY 2023: -88.5%FY 2024: -181.7%FY 2025: 0.0%
FY 2016 5y median -181.7% FY 2025
ROE -34.4%
FY 2016: 469.8%FY 2017: 21.7%FY 2018: -329.1%FY 2019: -111.7%FY 2020: -48.4%FY 2021: -63.8%FY 2022: -246.2%FY 2023: -98.6%FY 2024: -27.8%FY 2025: -34.4%
FY 2016 5y median -63.8% FY 2025
ROIC -33.4%
FY 2016: -122.6%FY 2017: -88.1%FY 2018: -191.8%FY 2019: -75.7%FY 2020: -42.9%FY 2021: -55.7%FY 2022: -109.2%FY 2023: -85.3%FY 2024: -28.3%FY 2025: -33.4%
FY 2016 5y median -55.7% FY 2025
ROA -29.5%
FY 2016: -100.3%FY 2017: 14.9%FY 2018: -164.3%FY 2019: -68.8%FY 2020: -39.4%FY 2021: -48.4%FY 2022: -57.9%FY 2023: -37.9%FY 2024: -23.7%FY 2025: -29.5%
FY 2016 5y median -37.9% FY 2025

Growth (YoY)

Revenue -100.0%
FY 2016: -15.5%FY 2017: -16.4%FY 2018: -37.3%FY 2019: -39.9%FY 2020: -69.1%FY 2021: -21.1%FY 2022: 941.8%FY 2023: 886.8%FY 2024: -11.5%FY 2025: -100.0%
FY 2016 FY 2025
Operating Income -154.1%
FY 2016: -34.6%FY 2017: 24.2%FY 2018: -19.2%FY 2019: 49.5%FY 2020: -77.0%FY 2021: -52.9%FY 2022: -41.8%FY 2023: 18.9%FY 2024: -76.8%FY 2025: -154.1%
FY 2016 FY 2025
EPS (diluted) -96.5%
FY 2016: -25.3%FY 2017: 108.9%FY 2018: -674.4%FY 2019: 60.2%FY 2020: 57.3%FY 2021: 1.1%FY 2022: -35.6%FY 2023: 29.7%FY 2024: -38.6%FY 2025: -96.5%
FY 2016 FY 2025
Free Cash Flow -75.1%
FY 2016: -45.8%FY 2017: 10.8%FY 2018: 0.6%FY 2019: 51.9%FY 2020: -55.4%FY 2021: -69.8%FY 2022: 108.6%FY 2023: -1875.6%FY 2024: -50.2%FY 2025: -75.1%
FY 2016 FY 2025

Financial Health

Current Ratio 9.0×
FY 2016: 3.7×FY 2017: 9.4×FY 2018: 6.7×FY 2019: 11.7×FY 2020: 11.3×FY 2021: 8.8×FY 2022: 1.8×FY 2023: 1.6×FY 2024: 7.8×FY 2025: 9.0×
FY 2016 5y median 7.8× FY 2025
Quick Ratio 9.0×
FY 2016: 3.7×FY 2017: 9.4×FY 2018: 6.7×FY 2019: 11.7×FY 2020: 11.3×FY 2021: 8.8×FY 2022: 1.8×FY 2023: 1.6×FY 2024: 7.8×FY 2025: 9.0×
FY 2016 5y median 7.8× FY 2025
Debt / Equity 0.1×
FY 2016: -4.2×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.5×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.5×FY 2023: 0.2×FY 2024: 0.0×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 2.7×
FY 2016: -0.8×FY 2017: -0.9×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 2.1×FY 2021: 1.4×FY 2022: 0.1×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 2.7×
FY 2016 5y median 0.4× FY 2025
Interest Coverage -35.5×
FY 2016: -49.3×FY 2017: -32.3×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -35.5×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31